Evaluation of Patients with Acute Viral Hepatitis

dc.contributor.authorEker, Alper
dc.contributor.authorTansel, Ozlem
dc.contributor.authorKuloglu, Figen
dc.contributor.authorAkata, Filiz
dc.date.accessioned2024-06-12T11:03:08Z
dc.date.available2024-06-12T11:03:08Z
dc.date.issued2005
dc.departmentTrakya Üniversitesien_US
dc.description.abstractThirty-eight patients with acute viral hepatitis were admitted to Trakya University Hospital from January 2001 to June 2004. These patients were evaluated according to their complaints, clinical findings and laboratory results, retrospectively. Twenty-one (55.3%) of the patients were acute viral hepatitis A; 17 (44.7%) were acute viral hepatitis B. In SPSS software, clinical findings were evaluated with Fisher's exact test and laboratory results were evaluated in independent groups with non parametric t-test. The symptoms of the patients were weakness (85.7%, 88.2%), jaundice (85.7%, 88.2%), anorexia (76.2%, 52.9%), nausea (76.2%, 64.7%), darkening of urine color (71.4%, 76.5%), vomitting (57.1%, 41.2%) in hepatitis A and B, respectively. the signs of the patients were icterus (95.2%, 100%), hepatomegaly (28.6%, 47.1%), splenomegaly (9.5%, 23.5%) in hepatitis A and B, respectively. The-re was no significant difference in clinical findings. The mean age was 21.5 in hepatitis A and 33 in hepatitis B. In hepatitis A, mean aspartate aminotransferase (AST) value was 1345 U/L and mean alanine aminotransferase (ALT) value was 1910 U/L; in hepatitis B mean AST value was 1475 U/L, mean ALT was 2445 U/L. The level of ALT in hepatitis B cases was significantly higher than hepatitis A. In hepatitis A, mean total bilirubin value was 5.9 mg/dL, direct bilirubin was 3.5 mg/dL. In hepatitis B, total bilirubin was found 11.4 mg/dL, direct bilirubin was 7.7 mg/dL. Bilirubin levels in hepatitis B cases were significiantly higher than hepatitis a cases. There was no significant difference between two groups in the other laboratory findings. Although ALT and bilirubin levels in hepatitis B is higher than hepatitis A, the etiology of acute viral hepatitis can not be determined with the initial clinical and laboratory results.en_US
dc.identifier.endpage149en_US
dc.identifier.issn1307-9441
dc.identifier.issn2147-2939
dc.identifier.issue3en_US
dc.identifier.startpage144en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/21549
dc.identifier.volume10en_US
dc.identifier.wosWOS:000217138900004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isotren_US
dc.publisherGalenos Yayinciliken_US
dc.relation.ispartofViral Hepatit Dergisi-Viral Hepatitis Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis Aen_US
dc.subjectHepatitis Ben_US
dc.subjectClinical Findingsen_US
dc.subjectLaboratory Resultsen_US
dc.titleEvaluation of Patients with Acute Viral Hepatitisen_US
dc.typeArticleen_US

Dosyalar